Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Disruption of microtubule function is the antitumor mechanism of several classes of drugs used to treat cancer today. However, the significant beneficial effect on tumor outcomes is frequently counterbalanced by neurotoxic complications. Despite an abundance of scientific data, our understanding of...
Main Authors: | Gerald M. Higa, Corbin Sypult |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S32810 |
Similar Items
-
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
by: Gerald M. Higa, et al.
Published: (2016-04-01) -
Vagus Nerve Stimulation Transiently Mitigates Chemotherapy-Induced Peripheral Neuropathy in Rats
by: Zhang R, et al.
Published: (2020-12-01) -
Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
by: Jennifer M. Brazill, et al.
Published: (2018-06-01) -
Antioxidant and Anti-Inflammatory Potential of Thymoquinone and Lycopene Mitigate the Chlorpyrifos-Induced Toxic Neuropathy
by: Mohamed Aboubakr, et al.
Published: (2021-09-01) -
Clinical Approaches to the Treatment of Diabetic Neuropathy
by: A.V. Kaminsky
Published: (2014-04-01)